Selpercatinib US FDA Label
- Compound: 6-(2-hydroxy-2-methylpropoxy)-4-[6-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]-3-pyridinyl]pyrazolo[1,5-a]pyridine-3-carbonitrile
- Description: NA
- Brand Name:
- Code(s): CEGM9YBNGD
- Approved:
- Kinase Class: RY
- Inhibitor Type: I ½B
- Literature (PubMed): 0
- Target(s): RET proto-oncogene
- Disease(s): medullary thyroid cancer , non-small-cell lung carcinoma